Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (141-150 of 395) with videos related to

Pageof 40
Sort By:
Clinical Endocrinology|April 28, 2011
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in womenPer Johansson, Jan-Ove Johansson, Fernand Labrie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersLina Lu, Alexa Pichet Binette, Shorena Janelidze, et al.
JAMA Neurology|June 25, 2019
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid StatusSebastian Palmqvist, Shorena Janelidze, Erik Stomrud, et al.
Nature Medicine|May 25, 2021
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measuresSebastian Palmqvist, Pontus Tideman, Nicholas Cullen, et al.
Nature Communications|June 12, 2021
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populationsNicholas C Cullen, Antoine Leuzy, Shorena Janelidze, et al.
Neurobiology of Aging|August 23, 2019
Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adultsRachel L Nosheny, Philip S Insel, Niklas Mattsson, et al.
Neurology|September 8, 2021
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 AssaysAntoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Plos One|December 7, 2013
Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's diseasePer Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Neuromolecular Medicine|October 9, 2013
Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's diseaseAndrea Armstrong, Niklas Mattsson, Hanna Appelqvist, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 11, 2026
Turning as a single and dual task-associations with alzheimer's and vascular pathologies in cognitively healthy older peopleMaria H Nilsson, Magnus Lindh-Rengifo, Lynn Rochester, et al.
Pageof 40

Showing results (141-150 of 395) with videos related to

Sort By:
Pageof 40
Clinical Endocrinology|April 28, 2011
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in womenPer Johansson, Jan-Ove Johansson, Fernand Labrie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersLina Lu, Alexa Pichet Binette, Shorena Janelidze, et al.
JAMA Neurology|June 25, 2019
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid StatusSebastian Palmqvist, Shorena Janelidze, Erik Stomrud, et al.
Nature Medicine|May 25, 2021
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measuresSebastian Palmqvist, Pontus Tideman, Nicholas Cullen, et al.
Nature Communications|June 12, 2021
Plasma biomarkers of Alzheimer's disease improve prediction of cognitive decline in cognitively unimpaired elderly populationsNicholas C Cullen, Antoine Leuzy, Shorena Janelidze, et al.
Neurobiology of Aging|August 23, 2019
Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adultsRachel L Nosheny, Philip S Insel, Niklas Mattsson, et al.
Neurology|September 8, 2021
Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 AssaysAntoine Leuzy, Shorena Janelidze, Niklas Mattsson-Carlgren, et al.
Plos One|December 7, 2013
Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's diseasePer Johansson, Erik G Almqvist, Jan-Ove Johansson, et al.
Neuromolecular Medicine|October 9, 2013
Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's diseaseAndrea Armstrong, Niklas Mattsson, Hanna Appelqvist, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 11, 2026
Turning as a single and dual task-associations with alzheimer's and vascular pathologies in cognitively healthy older peopleMaria H Nilsson, Magnus Lindh-Rengifo, Lynn Rochester, et al.
Pageof 40